Viela Bio, Inc. Common Stock
VIE
VIE was delisted on the 12th of March, 2021.
47 hedge funds and large institutions have $732M invested in Viela Bio, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
42% more capital invested
Capital invested by funds: $516M → $732M (+$216M)
24% more funds holding
Funds holding: 38 → 47 (+9)
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
0.5% more ownership
Funds ownership: 37.28% → 37.78% (+0.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$10.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.51M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$2.26M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$2.15M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$9.25M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$2.9M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.56M |
| 4 |
JP Morgan Chase
New York
|
-$812K |
| 5 |
D.E. Shaw & Co
New York
|
-$805K |
VIE Hedge Fund Activity: Q1 2020 in Review
47 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Viela Bio, Inc. Common Stock (VIE) for Q1 2020, worth a combined $732M — up 42% from $516M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VIE positions and 3 closed out — a net gain of 9 holders — while 16 added to existing stakes and 15 trimmed.
The largest buyer was Cormorant Asset Management, adding an estimated $10.3M. The largest seller was Viking Global Investors, cutting an estimated $9.25M.
- 47 institutional investors held Viela Bio, Inc. Common Stock (VIE) as of Q1 2020, up from 38 in Q4 2019.
- Funds reported $732M of Viela Bio, Inc. Common Stock stock for Q1 2020, up 42% quarter-over-quarter.
- 12 funds opened new Viela Bio, Inc. Common Stock positions in Q1 2020 and 3 closed out, a net change of +9 holders.
- The largest Viela Bio, Inc. Common Stock buyer in Q1 2020 was Cormorant Asset Management, an estimated $10.3M added.
- The largest Viela Bio, Inc. Common Stock seller in Q1 2020 was Viking Global Investors, an estimated $9.25M sold.
Based on aggregated 13F filings for Q1 2020.